ALK and anaplastic large cell lymphoma: Anaplastic lymphoma kinase (ALK), a tyrosine kinase receptor residing on chromosome 2p23 was first described in a subset of anaplastic large cell lymphoma (ALCL) patients as part of a chromosomal rearrangement with nucleophosmin as a fusion partner [7].